A Phase 1b Open-label Study to Evaluate Safety of Plamotamab in Participants With Rheumatoid Arthritis

NCT07230353 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
68
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Xencor, Inc.